Behavioral context improves optogenetic stimulation of transplanted dopaminergic cells in unilateral 6-OHDA rats

[1]  U. Hochgeschwender,et al.  Restoring Function After Severe Spinal Cord Injury Through BioLuminescent-OptoGenetics , 2022, Frontiers in Neurology.

[2]  D. Covey,et al.  Evolution of in vivo dopamine monitoring techniques , 2020, Pharmacology Biochemistry and Behavior.

[3]  M. Abdollahifar,et al.  Functional dopaminergic neurons derived from human chorionic mesenchymal stem cells ameliorate striatal atrophy and improve behavioral deficits in Parkinsonian rat model , 2019, Anatomical record.

[4]  Tetsuhiro Kikuchi,et al.  Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease , 2020, Nature Communications.

[5]  A. Björklund,et al.  Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective , 2020, Frontiers in Cellular Neuroscience.

[6]  U. Hochgeschwender,et al.  Bioluminescence‐driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model , 2020, Journal of neuroscience research.

[7]  A. Miyawaki,et al.  Novel luciferase–opsin combinations for improved luminopsins , 2020, Journal of neuroscience research.

[8]  Jiabing Shen,et al.  Clinical potential and current progress of mesenchymal stem cells for Parkinson’s disease: a systematic review , 2020, Neurological Sciences.

[9]  J. Takahashi,et al.  Exercise Promotes Neurite Extensions from Grafted Dopaminergic Neurons in the Direction of the Dorsolateral Striatum in Parkinson’s Disease Model Rats , 2020, Journal of Parkinson's disease.

[10]  Ying-Zu Huang,et al.  Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson's Disease , 2019, Behavioural neurology.

[11]  M. Sandstrom,et al.  Behavioral and neurochemical responses derived from dopaminergic intrastriatal grafts in hemiparkinsonian rats engaged in a novel motor task , 2018, Journal of Neuroscience Methods.

[12]  U. Hochgeschwender,et al.  Neural Stem Cells Derived Directly from Adipose Tissue. , 2018, Stem cells and development.

[13]  Dong-Ming Huang,et al.  Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease. , 2018, Nanoscale.

[14]  M. Sandstrom,et al.  Plastic Adaptation: A Neuronal Imperative Capable of Confounding the Goals of Stem Cell Replacement Therapy for either Huntington’s or Parkinson’s Disease , 2017, Neuroplasticity - Insights of Neural Reorganization.

[15]  M. Curado,et al.  Anodal Transcranial Direct Current Stimulation Enhances Survival and Integration of Dopaminergic Cell Transplants in a Rat Parkinson Model , 2017, eNeuro.

[16]  Xiao Fan,et al.  Stem cell transplantation for spinal cord injury: a meta-analysis of treatment effectiveness and safety , 2017, Neural regeneration research.

[17]  B. Velasques,et al.  Proposal for using time estimation training for the treatment of Parkinson's disease. , 2016, Medical hypotheses.

[18]  Jakob Kisbye Dreyer,et al.  How compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatum , 2016, Movement disorders : official journal of the Movement Disorder Society.

[19]  George J Augustine,et al.  Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation , 2016, Proceedings of the National Academy of Sciences.

[20]  O. Lindvall.  Clinical translation of stem cell transplantation in Parkinson's disease , 2016, Journal of internal medicine.

[21]  Karl Deisseroth,et al.  Optogenetics enables functional analysis of human embryonic stem cell–derived grafts in a Parkinson's disease model , 2015, Nature Biotechnology.

[22]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[23]  A. Willis.  Parkinson disease in the elderly adult. , 2013, Missouri medicine.

[24]  F. Rossi,et al.  Influence of the environment on adult CNS plasticity and repair , 2012, Cell and Tissue Research.

[25]  N. Spitzer,et al.  Reserve pool neuron transmitter respecification: Novel neuroplasticity , 2012, Developmental neurobiology.

[26]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2016 .

[27]  C. Freed,et al.  Dopamine Cell Transplantation for Parkinson’s Disease: The Importance of Controlled Clinical Trials , 2011, Neurotherapeutics.

[28]  Karl Deisseroth,et al.  Functional Integration of Grafted Neural Stem Cell-Derived Dopaminergic Neurons Monitored by Optogenetics in an In Vitro Parkinson Model , 2011, PloS one.

[29]  U. Wyneken,et al.  Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[30]  E. Parati,et al.  Stem Cell Transplantation for Ischemic Stroke , 2010, The Cochrane database of systematic reviews.

[31]  Tobias Piroth,et al.  Review: Neurorehabilitation With Neural Transplantation , 2010, Neurorehabilitation and neural repair.

[32]  M. Nowycky,et al.  Brain‐derived neurotrophic factor facilitates maturation of mesenchymal stem cell‐derived dopamine progenitors to functional neurons , 2009, Journal of neurochemistry.

[33]  J. Roh,et al.  Stem Cells Transplantation and Huntington's Disease. , 2009, International journal of stem cells.

[34]  D. Guilloteau,et al.  Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease , 2008, Neurochemistry International.

[35]  S. V. Anisimov,et al.  Transplantation of Human Embryonic Stem Cell‐Derived Cells to a Rat Model of Parkinson's Disease: Effect of In Vitro Differentiation on Graft Survival and Teratoma Formation , 2006, Stem cells.

[36]  Robert T Kennedy,et al.  In vivo measurements of neurotransmitters by microdialysis sampling. , 2006, Analytical chemistry.

[37]  Gwang Lee,et al.  Autologous mesenchymal stem cell transplantation in stroke patients , 2005, Annals of neurology.

[38]  Martin Pera,et al.  Transplantation of Human Embryonic Stem Cell–Derived Neural Progenitors Improves Behavioral Deficit in Parkinsonian Rats , 2004, Stem cells.

[39]  W. Paulus,et al.  Behavioral Changes in Unilaterally 6‐Hydroxy‐Dopamine Lesioned Rats After Transplantation of Differentiated Mouse Embryonic Stem Cells Without Morphological Integration , 2004, Stem cells.

[40]  Vesna Sossi,et al.  A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease , 2003, Annals of neurology.

[41]  G. Miller,et al.  Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease , 2003, Neuroscience.

[42]  Bruce G. Jenkins,et al.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Dunnett,et al.  The influence of environment and experience on neural grafts , 2001, Nature Reviews Neuroscience.

[44]  J Q Trojanowski,et al.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.

[45]  S. Dunnett,et al.  Survival, Neuronal Differentiation, and Fiber Outgrowth of Propagated Human Neural Precursor Grafts in an Animal Model of Huntington's Disease , 2000, Cell transplantation.

[46]  T. Robbins,et al.  Associative plasticity in striatal transplants. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Zigmond.  Do Compensatory Processes Underlie the Preclinical Phase of Neurodegenerative Disease? Insights from an Animal Model of Parkinsonism , 1997, Neurobiology of Disease.

[48]  N Birbaumer,et al.  Short‐term effects of behavioral treatment on movement initiation and postural control in Parkinson's disease: A controlled clinical study , 1997, Movement disorders : official journal of the Movement Disorder Society.

[49]  P. Garris,et al.  Real‐Time Measurement of Electrically Evoked Extracellular Dopamine in the Striatum of Freely Moving Rats , 1997, Journal of neurochemistry.

[50]  A. Grace.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[51]  T. Robinson,et al.  Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  Ann Vennelle.  Therapy following Replantation of a Hand , 1988 .

[53]  I. Whishaw,et al.  Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions , 1987, Brain Research.

[54]  P. Lu.  Stem cell transplantation for spinal cord injury repair. , 2017, Progress in brain research.

[55]  Scott H. Frey,et al.  Why Brain Science is Essential to the Success of Hand Allotransplantation , 2015 .

[56]  G. Nikkhah,et al.  Role of experience, training, and plasticity in the functional efficacy of striatal transplants. , 2012, Progress in brain research.

[57]  L. Studer.  Derivation of dopaminergic neurons from pluripotent stem cells. , 2012, Progress in brain research.

[58]  J. Tepper,et al.  Basal ganglia control of substantia nigra dopaminergic neurons. , 2009, Journal of neural transmission. Supplementum.